Glassberg MK. Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape. Am J Manag Care. 2019;25(11 Suppl):S195–203.
Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, et al. Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther. 2021;222:107798.
Article CAS PubMed Google Scholar
Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 2022;17:515–46.
Article CAS PubMed Google Scholar
Mortimer KM, Bartels DB, Hartmann N, Capapey J, Yang J, Gately R, et al. Characterizing health outcomes in idiopathic pulmonary fibrosis using US health claims data. Respiration. 2020;99(2):108–18.
Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Resp Res. 2021;22(1):197.
Mei Q, Liu Z, Zuo H, Yang Z, Qu J. Idiopathic pulmonary fibrosis: an update on pathogenesis. Front Pharmacol. 2022;12.
Allaix ME, Rebecchi F, Morino M, Schlottmann F, Patti MG. Gastroesophageal reflux and idiopathic pulmonary fibrosis. World J Surg. 2017;41(7):1691–97.
Reynolds CJ, Del Greco MF, Allen RJ, Flores C, Jenkins RG, Maher TM et al. The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample mendelian randomisation study. Eur Respir J 2023;61(5).
Alhamad EH, Cal JG, Alrajhi NN, Aharbi WM, AlRikabi AC, AlBoukai AA. Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis. Ann Thorac Med. 2020;15(4):208–14.
Article PubMed PubMed Central Google Scholar
Xu L, Lee JH, Jang JH, Park JH, Lee S, Kim JY et al. Prevalence and clinical impacts of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: a single-center, retrospective study. PLoS ONE. 2023;18(9).
Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne). 2021;12:706978.
Cheng X, Jiang S, Pan B, Xie W, Meng J. Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role. Lipids Health Dis. 2023;22(1):201.
Article CAS PubMed PubMed Central Google Scholar
Ma Y, Feng C, Tang H, Deng P, Li Y, Wang J, et al. Management of BMI is a potential new approach for the prevention of idiopathic pulmonary fibrosis. Front Genet. 2022;13:821029.
Article CAS PubMed PubMed Central Google Scholar
Awano N, Jo T, Yasunaga H, Inomata M, Kuse N, Tone M et al. Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis. Erj Open Res. 2021;7(2).
Jouneau S, Kerjouan M, Rousseau C, Lederlin M, Llamas-Guttierez F, De Latour B, et al. What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center. Nutrition. 2019;62:115–21.
Sangani RG, Ghio AJ, Mujahid H, Patel Z, Catherman K, Wen S, et al. Outcomes of idiopathic pulmonary fibrosis improve with obesity: a rural appalachian experience. South Med J. 2021;114(7):424–31.
Article CAS PubMed PubMed Central Google Scholar
Jouneau S, Crestani B, Thibault R, Lederlin M, Vernhet L, Yang M, et al. Post hoc analysis of clinical outcomes in placebo- and pirfenidone-treated patients with IPF stratified by BMI and weight loss. Respiration. 2022;101(2):142–54.
Article CAS PubMed Google Scholar
Lee JS, Martin-Schwarze A, Freiheit E, Trzaskoma B, Burg C. Real-world clinical outcomes based on body mass index and annualized weight change in patients with idiopathic pulmonary fibrosis. Adv Ther. 2023;40(2):691–704.
Alakhras M, Decker PA, Nadrous HF, Collazo-Clavell M, Ryu JH. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest. 2007;131(5):1448–53.
Jouneau S, Rousseau C, Lederlin M, Lescoat A, Kerjouan M, Chauvin P, et al. Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients. Clin Nutr. 2022;41(6):1335–42.
Article CAS PubMed Google Scholar
Sangani RG, Ghio AJ, Mujahid H, Patel Z, Catherman K, Wen SJ, et al. Outcomes of idiopathic pulmonary fibrosis improve with obesity: a rural appalachian experience. South Med J. 2021;114(7):424–31.
Article CAS PubMed PubMed Central Google Scholar
Comes A, Wong AW, Fisher JH, Morisset J, Johannson KA, Farrand E, et al. Association of BMI and change in weight with mortality in patients with fibrotic interstitial lung disease. Chest. 2022;161(5):1320–29.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj-British Med J. 2015;349:g7647.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting. Jama-Journal Am Med Association. 2000;283(15):2008–12.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–05.
Higgins JPT, Altman DG, Gotzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. Bmj-British Med J. 2011;343:d5928.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Article CAS PubMed PubMed Central Google Scholar
Duval S, Tweedie R. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta‐analysis. Biometrics. 2004;56(2):455–63.
Li B, Zhang X, Xu G, Zhang S, Song H, Yang K, et al. Serum prealbumin is a prognostic indicator in idiopathic pulmonary fibrosis. Clin Respir J. 2019;13(8):493–98.
Article CAS PubMed Google Scholar
Nakatsuka Y, Handa T, Kokosi M, Tanizawa K, Puglisi S, Jacob J, et al. The clinical significance of body weight loss in idiopathic pulmonary fibrosis patients. Respiration. 2018;96(4):338–47.
Suzuki Y, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, et al. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis. Sci Rep-uk. 2018;8:14074.
Kono M, Nakamura Y, Enomoto N, Saito G, Koyanagi Y, Miyashita K, et al. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone. Respiratory Invest. 2019;57(6):552–60.
Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Enomoto N, Nakamura Y, et al. The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis. Respirology. 2018;23(5):519–25.
Suzuki Y, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, et al. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy. Respirology. 2021;26(2):171–79.
Yoo JW, Kim J, Song JW. Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis. Sci Rep-uk. 2022;12(1):8817.
Zinellu A, Collu C, Nasser M, Paliogiannis P, Mellino S, Zinellu E, et al. The Aggregate Index of systemic inflammation (AISI): a novel prognostic biomarker in idiopathic pulmonary fibrosis. J Clin Med. 2021;10:18.
Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012;40(1):101–09.
Comments (0)